By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Tesaro (TSRO) Announces Expanded Development Program For Niraparib Focused On The Treatment Of Front-Line Metastatic Ovarian And Lung Cancers And Metastatic Breast Cancer 3/28/2017 10:01:28 AM
FDA Clears Massachusetts Biotech Tesaro (TSRO)'s Ovarian Cancer PARP Inhibitor 3/27/2017 2:19:13 PM
AstraZeneca PLC (AZN) Steals Tesaro (TSRO)'s PARP Thunder With Phase III Ovarian Cancer Data 3/15/2017 6:15:25 AM
Tesaro (TSRO) Announces Niraparib Data Presentations At The 2017 SGO Annual Meeting On Women's Cancer 3/13/2017 8:00:13 AM
Tesaro (TSRO) Announces Fourth-Quarter 2016 Operating Results 3/1/2017 9:41:54 AM
Tesaro (TSRO) Receives Positive CHMP Opinion For VARUBY 2/27/2017 8:21:40 AM
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug 2/17/2017 7:04:09 AM
Tesaro (TSRO) To Announce Fourth-Quarter 2016 Financial Results On February 28, 2017 2/15/2017 8:03:43 AM
Tesaro (TSRO) Announces Participation At Two Investor Conferences 2/3/2017 8:54:28 AM
Tesaro (TSRO) Biotech Announces Opening Of Niraparib Expanded Access Program For U.S. Patients With Ovarian Cancer 1/17/2017 6:58:00 AM